Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The Role of the Nuclear Deubiquitinase MYSM1 in the Transcriptional Regulation of Hematopoietic Stem Cell Function and Hematopoiesis

FY 2017-18

Summary
Throughout life, rare and essential stem cells residing deep within our bone marrow divide and mature into the entire repertoire of blood cells in the body, undergoing a complex process called hematopoiesis. Without it, we would not be able to deliver oxygen to our tissues, clot wounds, or have a functioning immune system. Hematopoiesis involves the intricate coordination of many genes, which serve as tiny molecular “blueprints” for building functional gene products. Dysregulation of this molecular clockwork can lead to various blood disorders and malignancies like Fanconi anemia and leukemia. To better understand or prevent these dire consequences, it is essential to have a solid understanding of the genes involved in normal hematopoiesis. MYSM1 is a specific gene product which can in turn regulate the genes essential for hematopoiesis. MYSM1-deficiency results in severe defects in blood stem cells and impairs production of the final blood cell repertoire, highlighting its central importance. We are investigating MYSM1 on a molecular level to determine which exact genes it regulates and how it regulates them, and whether it is acting alone or with other gene products to regulate hematopoiesis. This will expand our understanding of the role of MYSM1 in the blood system, and potentially reveal it to be a good therapeutic target for the treatment of diverse blood-related illnesses.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386572
Name
Fiore Amanda
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of the Nuclear Deubiquitinase MYSM1 in the Transcriptional Regulation of Hematopoietic Stem Cell Function and Hematopoiesis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chromatin; Cmyc; Deubiquitinase; Epigenetics; Gene Regulation; Hematology; Hematopoiesis; Hematopoietic Stem Cell; Mysm1; Ribosomal Protein
Abstract
Throughout life, rare and essential stem cells residing deep within our bone marrow divide and mature into the entire repertoire of blood cells in the body, undergoing a complex process called hematopoiesis. Without it, we would not be able to deliver oxygen to our tissues, clot wounds, or have a functioning immune system. Hematopoiesis involves the intricate coordination of many genes, which serve as tiny molecular “blueprints” for building functional gene products. Dysregulation of this molecular clockwork can lead to various blood disorders and malignancies like Fanconi anemia and leukemia. To better understand or prevent these dire consequences, it is essential to have a solid understanding of the genes involved in normal hematopoiesis. MYSM1 is a specific gene product which can in turn regulate the genes essential for hematopoiesis. MYSM1-deficiency results in severe defects in blood stem cells and impairs production of the final blood cell repertoire, highlighting its central importance. We are investigating MYSM1 on a molecular level to determine which exact genes it regulates and how it regulates them, and whether it is acting alone or with other gene products to regulate hematopoiesis. This will expand our understanding of the role of MYSM1 in the blood system, and potentially reveal it to be a good therapeutic target for the treatment of diverse blood-related illnesses.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fiore, Amanda
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~